Mirae Asset Global Investments Co., Ltd. Maxcyte, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Maxcyte, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,515 shares of MXCT stock, worth $15,290. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,515
Previous 3,801
7.52%
Holding current value
$15,290
Previous $14,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding MXCT
# of Institutions
125Shares Held
66MCall Options Held
1KPut Options Held
2K-
Cadian Capital Management, LP New York, NY8.19MShares$35.6 Million1.63% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$35.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.78MShares$25.1 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$21.9 Million7.62% of portfolio
-
Morgan Stanley New York, NY4.82MShares$21 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $442M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...